Letter from CJ Collins, Armour Pharmaceutical Company Limited to the Variations Section of the Department of Health & Social Security, regarding an application for variations to the product licence of 0231/0038 Factorate and 0231/0044 High Potency Factorate. The variation relates to the inclusion of a heat treatment stage in the processing of the products.